揭开质母细胞瘤的非编码RNA景观:从致病源到精密治疗方法
1Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, 603203, Tamil Nadu, India.
Naunyn-Schmiedeberg's archives of pharmacology
|July 15, 2024
概括
非编码RNAs (ncRNAs) 显著调节质母细胞瘤 (GBM) 的进展和治疗耐药性. 通过RNA干扰策略向这些致癌性ncRNA,为改善GBM患者的治疗结果提供了一个有希望的治疗途径.
科学领域:
- 神经瘤学神经瘤学
- 分子生物学分子生物学
- 在RNA治疗方面,RNA疗法.
背景情况:
- 质母细胞瘤 (GBM) 是一种具有侵略性的脑瘤,治疗选择有限,预后不佳.
- 非编码RNAs (ncRNAs) 越来越被认为是GBM发展,进展和治疗耐药性的关键参与者.
- 各种ncRNA类型的失调,包括长ncRNAs (lncRNAs),microRNAs (miRNAs) 和圆形RNAs (circRNAs),在GBM中很常见.
研究的目的:
- 审查ncRNAs在GBM病原发生中的关键作用,包括它们对细胞增殖,迁移,血管生成和入侵的影响.
- 探索针对ncRNAs作为GBM新治疗策略的潜力.
- 突出RNA干扰策略,以调节在GBM治疗中的ncRNA表达.
主要方法:
- 文献综述侧重于GBM中ncRNAs的分子机制.
- 用各种RNA干扰方法研究针对ncRNA的治疗潜力的研究分析.
- 检查特定的ncRNAs (例如,miR-21,HOTAIR,circFOXO3) 及其在GBM中的致癌功能.
主要成果:
- ncRNAs显著影响GBM的标志性特征,如血管生成,迁移和入侵.
- 特定的miRNAs (例如miR-21) 和lncRNAs (例如HOXD-AS2) 作为瘤基因,促进GBM生长和转移.
- 循环RNAs (例如,circ0001730) 也有助于GBM细胞的生长和活力.
- 在临床前模型中,RNA干扰策略 (例如ASO,LNA,PNA) 在抑制GBM途径和瘤进展方面表现出有效性.
结论:
- ncRNAs是GBM的关键调节者,并具有作为治疗点的巨大潜力.
- 用RNA干扰策略准瘤性ncRNA是一种有前途的方法,可以改善GBM治疗和患者预后.
- 对基于ncRNA的治疗方法的进一步研究可能会为GBM患者带来更好的结果.
更多相关视频
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.5K
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
12.9K
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
